Pfizer is making a major push to leverage mRNA technology, on which its Covid-19 vaccine is based, to develop new vaccines and treatments.
Posted inTechnology News
Pfizer to pay Beam $300 million in gene-editing deal, amping up its mRNA ambitions – Stat News
